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SHOULD BENIGN HEPATIC TUMOURS BE EXCISED?
ABSTRACT
Iwatsuki, S., Todo, S. and Starzl, T.E. (1990) Excisional therapy for benign hepatic
lesions. Surgery Gynecology & Obstetrics; 171" 240-246.
With the recent advances in imaging techniques, increased numbers of hepatic
lesions are found today, and surgeons are asked frequently for the best course of
management. Benign hepatic tumors sometimes cause life-threatening complications
and more often trigger disabling or annoying symptoms in otherwise healthy
individuals. Although various imaging techniques are quite accurate in identifying
cysts and hemangiomas, other benign hepatic lesions, such as adenomas, focal
nodular hyperplasia and other benign solid tumors, cannot be differentiated from
malignant lesions with a high degree of confidence.
PAPER DISCUSSION
KEYWORDS" Benign hepatic tumour, liver resection
Iwatsuki and his colleagues reported the results of 219 hepatic resections for benign
lesions out of 547 consecutive liver resections between October 1964 to June 1989.
Only 5 patients died giving a 30 day hospital mortality of 2.3% and 14 patients
(6.4%) developed post-operative complications.
Based on these excellent results, the authors advocated resections for benign
lesions because of symptomatic relief, avoidance of haemorrhage from rupture and
confirmation of the benign nature whenever diagnosis was uncertain.
In their experience, over 40% of all hepatic resections were for benign lesions.
However achievement of technical excellence is not an argument for resection
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which remains the most effective therapy for primary hepatic malignancies. Since
benign liver tumours have been found in up to 2% of patients in autopsy series,
with widespread use of ultrasound investigations, detection of hepatic lesions will
increase and surgeons will increasingly be consulted for management decisions.
If one can exclude conditions such as cysts, abscesses, tuberculomas, gummas
and infiltrative or storage disorders which can be misdiagnosed as hepatic
neoplasms
2 one can still be left with diagnostic uncertainty in a small minority of
patients. This is particularly true in areas with high incidence of hepatocellular
carcinoma (HCC) where this tumour is associated with post-hepatitis B cirrhosis.
Despite radioactive isotope scanning, computerized tomography, magnetic reso-
nance imaging and superselective angiography, the differentiation between a
hyperplastic cirrhotic nodule and a small HCC can be difficult since both lesions
give similar appearance on ultrasound and selective angiography4’5. Hepatic
intra-arterial injection of lipiodol combined with computerized tomography
increases the sensitivity and specificity in the diagnosis of small ncc3’68. However
false positive can still occur. Besides HCC, lipiodol uptake and retention have been
reported in other primary and secondary liver tumours5’8, haemangiomas4’58 focal
nodular hyperplasia and nodular regenerative hyperplasia8.
One differentiating characteristic is that the deposited lipiodol is cleared within a
few weeks in a benign lesion while a malignant lesion will retain it for several
months5. However to wait for weeks before a clinical decision can be made in
patients with suspected malignancy, which may potentially be curable by liver
resection, is unsatisfactory. We have found that lesions which retain lipiodol give a
much brighter ultrasound image and facilitate ultrasound guided needle biopsy. To
ensure that the biopsy obtained is in the area of interest, the sample must be stained
for lipiodol, the technique of which we have now refined9. Despite the refinements
in techniques of percutaneous needle biopsy under guidance of ultrasound, compu-
terized tomography or laparoscopy, liver resections are still necessary in the
management of dubious lesions.
Significant bleeding can occur in about 0.2% of percutaneous needle biopsies
with a 0.1% mortality1. The risk of bleeding increases in patients with coagulo-
pathy and in biopsy of vascular lesions like cavernous haemangioma as reported in
this paper. Interestingly spontaneous rupture of adenoma which is a rare condition
occurred in 6 out of 25 patients presenting as haemoperitoneum. In our locality
9.7% of HCC may rupture spontaneously and present as haemoperitoneum.
Emergency resection, ligation of hepatic artery, plication of the bleeding points
with packing have all been tried with limited success1. We now advocate superse-
lective angiographic embolization if the patient’s condition is reasonably stable or
12 intratumoral injection of absolute alcohol to control haemorrhage when con-
fronted at laparotomy.
In the treatment of hepatic neoplasms the risks of liver resection have to be
balanced against the quality and quantity of survival. In general, good risks patients
with resectable malignant lesions should undergo liver resection as only surgery
offers the hope of cure. For benign lesions the majority are small to moderate size
and are usually asymptomatic. Once the diagnosis is confirmed, these should be
observed and monitored with repeated ultrasound assessments, particularly in the
first 2 years to avoid the potential danger of misdiagnosis. Liver cell adenoma, with
a high incidence of spontaneous rupture and difficulty to differentiate from a well
differentiated HCC on needle biopsy is a possible exception to this rule. For largeHPB INTERNATIONAL 253
symptomatic benign lesions or for those when malignancy cannot be excluded, the
treatment of choice must still be hepatic resection. The rapid advances of liver
surgery in the past two decades have made liver resection safe enough to advocate
such a policy of treatment13. Experienced liver surgeons now report a mortality for
major resection of less than 5% and even nil mortality is being reported in
moderately sized series14. The good results reported by the authors of this paper
further support this view.
It must be emphasized that the majority of benign lesions can be observed and
that liver resection for benign conditions is not a minor undertaking. Good clinical
results can only be obtained by surgeons experienced in liver surgery and by the
team approach to the problem.
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